Kruse et al., 1991 - Google Patents
Dosage frequency and drug-compliance behaviour—a comparative study on compliance with a medication to be taken twice or four times dailyKruse et al., 1991
View PDF- Document ID
- 9528285573752053312
- Author
- Kruse W
- Eggert-Kruse W
- Rampmaier J
- Runnebaum B
- Weber E
- Publication year
- Publication venue
- European journal of clinical pharmacology
External Links
Snippet
The objective of the study was to investigate patient compliance with two different dosage regimens. Ethinyloestradiol 80 μg daily was prescribed to 35 female outpatients to be taken as 20 μg four times daily or 40 μg twice daily for 7 days. It was given to standardise cervical …
- 239000003814 drug 0 title abstract description 47
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
- A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
- A61B5/4343—Pregnancy and labour monitoring, e.g. for labour onset detection
- A61B5/435—Assessing cervix alteration or dilation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kruse et al. | Dosage frequency and drug-compliance behaviour—a comparative study on compliance with a medication to be taken twice or four times daily | |
Aitken et al. | Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy | |
Harman et al. | KEEPS: the Kronos early estrogen prevention study | |
Friedlander | The physiology, medical management and oral implications of menopause | |
Elnashar et al. | Letrozole induction of ovulation in women with clomiphene citrate–resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio | |
Brough et al. | Effects of nutrient intake, surgery, sepsis, and long term administration of steroids on muscle function. | |
Skjelbred et al. | Acetylsalicylic acid vs paracetamol: effects on post-operative course | |
JP5555631B2 (en) | Compositions and means for treating uterine leiomyoma, leiomyoma, myoma, uterine fibroid, endometriosis, or adenomyosis with mifepristone | |
Wallace et al. | Hormone replacement therapy acceptability to Nottingham post-menopausal women with a risk factor for osteoporosis | |
Dionne et al. | Enhanced analgesia and suppression of plasma β‐endorphin by the S (+)‐isomer of ibuprofen | |
MCGEE et al. | Apathetic thyroidism: review of the literature and report of four cases | |
Ferguson et al. | Spironolactone and hydrochlorothiazide in normal‐renin and low‐renin essential hypertension | |
Jain et al. | A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination | |
Herlitz et al. | Variability of chest pain in suspected acute myocardial infarction according to subjective assessment and requirement of narcotic analgesics | |
Rayburn et al. | Changes in insulin therapy during pregnancy | |
Unosson et al. | Influence of macro-nutrient status on recovery after hip fracture | |
Notelovitz | Metabolic effect of conjugated oestrogens (USP) on glucose tolerance | |
Pirhonen et al. | The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study | |
Sullivan et al. | Emergent management of the patient in preterm labor | |
Agostini et al. | Influence of clinical and ultrasound factors on the efficacy of misoprostol in first trimester pregnancy failure | |
Craft et al. | ECG studies with astemizole | |
Lindberg | Adult preventive health screening: 1987 update | |
Torgrimson et al. | Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring | |
Vollebregt et al. | Association of three different techniques to measure blood pressure in the first trimester with the development of hypertensive disorders of pregnancy | |
Elian et al. | WEIGHT LOSS IN YOUNG OBESE SUBJECTS IMPROVES LIPIDS AND ADIPOKINES LEVELS AND REDUCES ARTERIAL STIFFNESS. |